Wändell P, Carlsson AC, Holzmann MJ, et al. Warfarin treatment and risk of stroke among primary care patients with atrial fibrillation. Scand Cardiovasc J. http://dx.doi.org/10.1080/14017431.2016.1215519
When the above article was first published online, the result in the abstract was “Persistent treatment with warfarin was present among 33.7% of women and 40.0% among men. Persistent warfarin treatment, compared to no persistent treatment, was associated with a stroke preventing effect with fully adjusted HRs of 0.25 (95%CI 0. 0.26–0.45) in women, and 0.25 (95%CI 0.28–0.43) in men”. This has now been corrected to “Persistent treatment with warfarin was present among 33.7% of women and 40.0% among men. Persistent warfarin treatment, compared to no persistent treatment, was associated with a stroke preventing effect with fully adjusted HRs of 0.25 (95%CI 0.18–0.36) in women, and 0.25 (95%CI 0.19–0.32) in men”.
The authors apologise for this error.